Population | Design | Outcome | Adverse effects | Validity | Remarks | Â |
---|---|---|---|---|---|---|
Pediatric | Randomized, double-blind, placebo-controlled, crossover | Clinical only | Nil | Not intention-to-treat due to dropouts, no quality of life measurement | Efficacy not concurred with [11] | [25] |
Adults | Randomized, double-blind, placebo-controlled, crossover | Clinical only | Nil | Not intention-to-treat due to dropouts, no quality of life measurement | Efficacy not concurred with [11] | |
Pediatric + Adults | Randomized, double-blind, placebo-controlled, crossover | Clinical only | Minor | Intention-to-treat, no dropouts, no quality of life measurement | No effects | [11] |
Pediatric | Randomized, double-blind, placebo-controlled | Clinical + quality of life + oral antihistamine and topical steroid-sparing | Minor | Intention-to-treat, no dropouts, quality of life + oral antihistamine and topical steroid usage sparing | Improved quality of life and steroid-sparing | [30] |
Adults | Randomized to 4 groups, saline as control | Poorly defined total effective rate and cured rate | Nil | Apparently no dropouts, but very small subgroups sizes, no quality of life measurement | Effective, difficult to assess efficacy | [31] |
Adults | Randomized, double-blind, placebo-controlled | Clinical + topical steroid and tacrolimus-sparing | Minor | Not intention-to-treat due to dropouts, no quality of life measurement | Topical steroid and tacrolimus-sparing only | [32] |